Clinical Trial

Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence

Study acronym: ANASTASIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Observational cohort study involving individuals of both sexes with a history of smoking, residing in municipalities in the state of Bahia and attended by the mobile unit, with the aim of evaluating the integration of artificial intelligence (AI) in the detection of pulmonary nodules and the prediction of ASCT in high-risk individuals undergoing CT screening.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-25.
Trial Details
NCT Number NCT07617636
Lead Sponsor AstraZeneca
Conditions Lung Cancer
Enrollment 1,500 participants
Start Date 2026-07-31
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-29